Studies on absorption of a newly developed enteric-coated erythromycin base.

Suppr

超能文献

作者信息

McDonald P J, Mather L E, Story M J

出版信息

J Clin Pharmacol. 1977 Oct;17(10 Pt 1):601-6. doi: 10.1177/009127007701701007.

DOI:10.1177/009127007701701007

PMID:915024

Abstract

摘要

相似文献

Studies on absorption of a newly developed enteric-coated erythromycin base.

J Clin Pharmacol. 1977 Oct;17(10 Pt 1):601-6. doi: 10.1177/009127007701701007.

Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.

J Clin Pharmacol. 1980 Jul;20(7):437-43. doi: 10.1002/j.1552-4604.1980.tb01716.x.

Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.

Infection. 1984 Sep-Oct;12(5):345-8. doi: 10.1007/BF01651150.

Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.

Eur J Clin Pharmacol. 1983;25(2):271-3. doi: 10.1007/BF00543802.

Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.

J Clin Pharmacol. 1985 Jan-Feb;25(1):36-42. doi: 10.1002/j.1552-4604.1985.tb02798.x.

[Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)].

Yakugaku Zasshi. 1978 Aug;98(8):1092-100. doi: 10.1248/yakushi1947.98.8_1092.

Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.

Antimicrob Agents Chemother. 1981 Aug;20(2):190-6. doi: 10.1128/AAC.20.2.190.

Intra- and intersubject variation of erythromycin absorption from single-unit and multiple-unit enteric-coated products.

Biopharm Drug Dispos. 1986 Mar-Apr;7(2):163-71. doi: 10.1002/bdd.2510070207.

[Erythromycin pharmacokinetics in children after rectal and oral administration].

Antibiot Khimioter. 1991 Feb;36(2):36-9.

Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.

Pharmacology. 1984;29(6):305-11. doi: 10.1159/000138029.

引用本文的文献

Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy.

Ann Clin Transl Neurol. 2015 Dec 10;3(1):42-54. doi: 10.1002/acn3.271. eCollection 2016 Jan.

Evaluation of the intestinal absorption of erythromycin in man: absolute bioavailability and comparison with enteric coated erythromycin.

Pharm Res. 1995 Jan;12(1):149-54. doi: 10.1023/a:1016215510223.

Absorption and bioavailability of oral erythromycin.

Br J Clin Pharmacol. 1981 Aug;12(2):131-40. doi: 10.1111/j.1365-2125.1981.tb01191.x.

Br J Clin Pharmacol. 1982 May;13(5):685-91. doi: 10.1111/j.1365-2125.1982.tb01437.x.

Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects.

Antimicrob Agents Chemother. 1982 Jan;21(1):135-40. doi: 10.1128/AAC.21.1.135.

Influence of food on absorption of erythromycin ethyl succinate.

Antimicrob Agents Chemother. 1980 Nov;18(5):829-31. doi: 10.1128/AAC.18.5.829.

Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.

Eur J Clin Pharmacol. 1983;25(2):271-3. doi: 10.1007/BF00543802.

Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers.

Eur J Clin Pharmacol. 1985;28(2):231-3. doi: 10.1007/BF00609699.

Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Clin Pharmacokinet. 1989 May;16(5):261-82. doi: 10.2165/00003088-198916050-00001.

The influence of food on the bioavailability of new formulations of erythromycin stearate and base.

Br J Clin Pharmacol. 1979 Oct;8(4):343-7. doi: 10.1111/j.1365-2125.1979.tb04716.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验